Adenocarcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Nrf2-peroxiredoxin I axis in polymorphous adenocarcinoma is associated with low matrix metalloproteinase 2 level.
|
28849259 |
2017 |
Adenocarcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The rates of CD44st and MMP2 expression were higher in squamous cell carcinomas than in adenocarcinomas, were closely associated with lymph node metastasis and TNM stage, and affected patients' prognoses.
|
28365695 |
2017 |
Adenocarcinoma
|
0.100 |
GeneticVariation
|
group |
BEFREE |
K-rasLSL-G12D mice were imaged serially during the development of adenocarcinomas using fluorescence molecular tomography (FMT) and a probe specific for MMP-2, -3, -9 and -13.
|
26193700 |
2015 |
Adenocarcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
In AC MMP2 had a worsening impact on survival (P = 0.021) and it had independent prognostic value (P = 0.002).
|
25337226 |
2014 |
Adenocarcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
MicroRNA-200b is overexpressed in endometrial adenocarcinomas and enhances MMP2 activity by downregulating TIMP2 in human endometrial cancer cell line HEC-1A cells.
|
23205572 |
2013 |
Adenocarcinoma
|
0.100 |
GeneticVariation
|
group |
LHGDN |
Polymorphisms of inflammatory and metalloproteinase genes, Helicobacter pylori infection and the risk of oesophageal adenocarcinoma.
|
18253117 |
2008 |
Adenocarcinoma
|
0.100 |
AlteredExpression
|
group |
LHGDN |
Circulating levels of VCAM and MMP-2 may help identify patients with more aggressive prostate cancer.
|
18473733 |
2008 |
Adenocarcinoma
|
0.100 |
Biomarker
|
group |
LHGDN |
Transmigration of human ovarian adenocarcinoma cells through endothelial extracellular matrix involves alphav integrins and the participation of MMP2.
|
15609323 |
2005 |
Adenocarcinoma
|
0.100 |
AlteredExpression
|
group |
LHGDN |
Hypoxia augments gelatinase activity in a variety of adenocarcinomas in vitro.
|
15820246 |
2005 |
Adenocarcinoma
|
0.100 |
Biomarker
|
group |
LHGDN |
MMP-2, MMP-2 activator, MT1-MMP, and its inhibitor (TIMP-2) were immunostained in 84 primary epithelial ovarian carcinomas (EOCs) (35 endometrioid adenocarcinomas [ECs] and 49 serous adenocarcinomas [SCs]).
|
14766248 |
2004 |
Adenocarcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Our results suggest that the type I is the major isoform of CD99 expressed in non-neoplastic gastric mucosa and gastric adenocarcinomas and its downregulation in gastric adenocarcinoma may be associated with cellular dedifferentiation and/or MMP-2 overexpression.
|
12172043 |
2002 |
Adenocarcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Adenocarcinoma cells in effusions showed a significant upregulation of MMP-2 expression compared with primary tumours, with a concomitant downregulation of TIMP-2.
|
11597382 |
2001 |
Adenocarcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
In the present study, we used in situ hybridization to study 36 primary hepatocellular carcinomas (HCCs) and 35 pancreatic adenocarcinomas to analyze the expressions of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 mRNAs.
|
10914717 |
2000 |
Adenocarcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
In this study, we investigated the immunohistochemical expression of MMP-2, MT1-MMP, TIMP-2, MMP-9, and TIMP-1 in 114 epithelial ovarian tumors (14 adenomas, 22 borderline tumors, and 78 adenocarcinomas). mRNA expression of MMP-2, MT1-MMP, and TIMP-2 was determined by RT-PCR in selected samples.
|
10995877 |
2000 |
Adenocarcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Expression of activated MMP-2 (72 kDa type IV collagenase) is highly associated with the malignant phenotype in adenocarcinomas, but predominant expression of the mRNA appears to be in stromal cells.
|
9490275 |
1998 |
Adenocarcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
ARCaP cells also secrete high levels of gelatinase A and B and some stromelysin, which suggests that this cell line may contain markers representing invasive adenocarcinoma with selective neuronendocrine phenotypes.
|
8986779 |
1996 |
Adenocarcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
Carcinoma cells showed diffuse deposition of gelatinase A in the cytosol, suggesting the accumulation of the antigen both in adenocarcinoma and squamous cell carcinoma.
|
7744701 |
1995 |